Bang, Y., Takano, T., Lin, C., Fasanmade, A., Yang, H., Danaee, H., . . . Doi, T. (2018). TAK-264 (MLN0264) in Previously Treated Asian Patients with Advanced Gastrointestinal Carcinoma Expressing Guanylyl Cyclase C: Results from an Open-Label, Non-randomized Phase 1 Study. Cancer Res Treat.
Chicago-tyylinen lähdeviittausBang, Yung-Jue, et al. "TAK-264 (MLN0264) in Previously Treated Asian Patients With Advanced Gastrointestinal Carcinoma Expressing Guanylyl Cyclase C: Results From an Open-Label, Non-randomized Phase 1 Study." Cancer Res Treat 2018.
MLA-viiteBang, Yung-Jue, et al. "TAK-264 (MLN0264) in Previously Treated Asian Patients With Advanced Gastrointestinal Carcinoma Expressing Guanylyl Cyclase C: Results From an Open-Label, Non-randomized Phase 1 Study." Cancer Res Treat 2018.